Meanwhile, the MTT and cell colony-forming assays showed that AKR1C3 knockdown can significantly suppress the proliferation of liver cancer cells treated with 10 μM sorafenib for 48 h (Figures 5D, E). The gene discussed is AKR1C3; the disease is liver cancer.